Basis: FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.
The P/E ratio is N/A as of 2026-10-06T14:50:44.557Z.
Calculation as of: 2026-10-06T14:50:44.557Z.
Quote observation: 2026-10-06T14:50:23.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: ad057aee5ab633aed0c7ef60ea3d5b85ea99b1ff07310db4f6411376a188a91d
PE RATIO
N/A
Market Cap
$847.73M
PE Ratio
N/A
TTM Avg
76.88
3Y Avg
76.88
5Y Avg
76.88
Market Cap
$870.53M
PE Ratio
N/A
TTM Avg
43.56
3Y Avg
43.56
5Y Avg
43.56
| NAME | MARKET CAP | PE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Alumis Inc. (ALMS) | $830.70M | N/A | N/A | N/A | N/A |
| Beta Bionics, Inc. (BBNX)vs › | $838.16M | N/A | N/A | N/A | N/A |
| Jade Biosciences, Inc. (JBIO)vs › | $819.02M | N/A | N/A | N/A | N/A |
| Monte Rosa Therapeutics, Inc. (GLUE)vs › | $847.73M | N/A | 76.88 | 76.88 | 76.88 |
| Ardelyx, Inc. (ARDX)vs › | $809.02M | N/A | 197.34 | 197.34 | 197.34 |
| Apnimed, Inc. (APMD)vs › | $807.90M | N/A | N/A | N/A | N/A |
| InMode Ltd. (INMD)vs › | $805.42M | 11.39 | 9.51 | 9.54 | 15.29 |
| Corvus Pharmaceuticals, Inc. (CRVS)vs › | $870.53M | N/A | 43.56 | 43.56 | 43.56 |
| AdaptHealth Corp. (AHCO)vs › | $784.35M | N/A | 16.88 | 41.08 | 41.08 |
| Gyre Therapeutics, Inc. (GYRE)vs › | $785.44M | N/A | 694.69 | 438.87 | 438.87 |
Trailing P/E
N/A
Forward P/E
N/A
Forward P/E is calculated using analyst consensus EPS estimates for the current or next fiscal year.
Calculation:
Current Price
$6.73
Forward EPS (Est.)
$-3.26
Forward P/E
N/A
Source: FMP Analyst Consensus Estimates. Forward EPS represents the average analyst estimate for the nearest fiscal year.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
